Storia in 5 fonti

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

Raccontata dacnbc.comft.comfortune.comupi.combbc.com

Confronto fonti

5 prospettive sulla stessa storia

AI · summaries

cnbc.comStai leggendo4 mesi fa

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

originale

upi.com4 mesi fa

Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.

Leggi questa versione → originale

bbc.com4 mesi fa

Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".

Leggi questa versione → originale

fortune.com4 mesi fa

Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.

Leggi questa versione → originale

ft.com4 mesi fa

Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

Shares in US company fall 16% after FDA announces investigation into unregulated medication

Leggi questa versione → originale

Timeline cronologica

1. sabato 7 febbraio 2026·cnbc.com
   

   US signals crackdown on compounded weight-loss drugs; Hims shares tumble

   The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.

2. sabato 7 febbraio 2026·ft.com
   

   Hims & Hers abandons copycat weight-loss drug in face of FDA probe

   Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy

3. sabato 7 febbraio 2026·cnbc.com
   

   Hims & Hers pulls copycat weight-loss pill after threats of legal action

   Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.

4. sabato 7 febbraio 2026·fortune.com
   

   Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

   The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.

5. lunedì 9 febbraio 2026·cnbc.com
   

   Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill

   Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.

6. lunedì 9 febbraio 2026·cnbc.com
   

   Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

   Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

7. lunedì 9 febbraio 2026·ft.com
   

   Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

   Shares in US company fall 16% after FDA announces investigation into unregulated medication

8. lunedì 9 febbraio 2026·upi.com
   

   Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

   Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.

9. martedì 10 febbraio 2026·bbc.com
   

   Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

   Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".